γc-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes

被引:49
作者
Kasprzycka, Monika [1 ]
Zhang, Qian [1 ]
Witkiewicz, Agnieszka [3 ]
Marzec, Michal [1 ]
Potoczek, Magdalena [3 ]
Liu, Xiaobin [1 ]
Wang, Hong Yi [1 ]
Milone, Michael [1 ]
Basu, Samik [1 ]
Mauger, Joanne [1 ]
Choi, John K. [1 ]
Abrams, J. Todd [4 ]
Hou, J. Steven [5 ]
Rook, Alain H. [2 ]
Vonderheid, Eric [6 ]
Woetmann, Anders [7 ]
Odum, Niels [7 ]
Wasik, Mariusz A. [1 ]
机构
[1] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[3] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pathol, Philadelphia, PA 19107 USA
[4] Lankenau Inst Med Res, Wynnewood, PA 19096 USA
[5] Drexel Univ, Dept Pathol, Philadelphia, PA 19129 USA
[6] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD 21287 USA
[7] Univ Copenhagen, Inst Mol Biol, Copenhagen, Denmark
关键词
D O I
10.4049/jimmunol.181.4.2506
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study, we demonstrate that malignant mature CD4(+) T lymphocytes derived from cutaneous T cell lymphomas (CTCL) variably display some aspects of the T regulatory phenotype. Whereas seven cell lines representing a spectrum of primary cutaneous T cell lymphoproliferative disorders expressed CD25 and TGF-beta, the expression of FOXP3 and, to a lesser degree, IL-10 was restricted to two CTCL cell lines that are dependent on exogeneous IL-2. IL-2, IL-15, and IL-21, all of which signals through receptors containing the common gamma chain, induced expression of IL-10 in the IL-2-dependent cell lines as well as primary leukemic CTCL cells. However, only IL-2 and IL-15, but not IL-21, induced expression of FOXP3. The IL-2-triggered induction of IL-10 and FOXP3 expression occurred by signaling through STAT3 and STAT5, respectively. Immunohistochemical analysis of the CTCL tissues revealed that FOXP3-expressing cells were common among the CD7-negative enlarged atypical and small lymphocytes at the early skin patch and plaque stages. Their frequency was profoundly diminished at the tumor stage and in the CTCL lymph node lesions with or without large cell transformation. These results indicate that the T regulatory cell features are induced in CTCL T cells by common gamma chain signaling cytokines such as IL-2 and do not represent a fully predetermined, constitutive phenotype independent of the local environmental stimuli to which these malignant mature CD4(+) T cells become exposed.
引用
收藏
页码:2506 / 2512
页数:7
相关论文
共 40 条
[1]   Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells [J].
Berger, CL ;
Tigelaar, R ;
Cohen, J ;
Mariwalla, K ;
Trinh, J ;
Wang, NC ;
Edelson, RL .
BLOOD, 2005, 105 (04) :1640-1647
[2]   Signal transducer and activator of transcription 5 (STAT5) [J].
Buitenhuis, M ;
Coffer, PJ ;
Koenderman, L .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (11) :2120-2124
[3]   IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells [J].
Burchill, Matthew A. ;
Yang, Jianying ;
Vogtenhuber, Christine ;
Blazar, Bruce R. ;
Farrar, Michael A. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (01) :280-290
[4]   Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor [J].
Changelian, PS ;
Flanagan, ME ;
Ball, DJ ;
Kent, CR ;
Magnuson, KS ;
Martin, WH ;
Rizzuti, BJ ;
Sawyer, PS ;
Perry, BD ;
Brissette, WH ;
McCurdy, SP ;
Kudlacz, EM ;
Conklyn, MJ ;
Elliott, EA ;
Koslov, ER ;
Fisher, MB ;
Strelevitz, TJ ;
Yoon, K ;
Whipple, DA ;
Sun, JM ;
Munchhof, MJ ;
Doty, JL ;
Casavant, JM ;
Blumenkopf, TA ;
Hines, M ;
Brown, MF ;
Lillie, BM ;
Subramanyam, C ;
Shang-Poa, C ;
Milici, AJ ;
Beckius, GE ;
Moyer, JD ;
Su, CY ;
Woodworth, TG ;
Gaweco, AS ;
Beals, CR ;
Littman, BH ;
Fisher, DA ;
Smith, JF ;
Zagouras, P ;
Magna, HA ;
Saltarelli, MJ ;
Johnson, KS ;
Nelms, LF ;
Des Etages, SG ;
Hayes, LS ;
Kawabata, TT ;
Finco-Kent, D ;
Baker, DL ;
Larson, M .
SCIENCE, 2003, 302 (5646) :875-878
[5]   Regulatory T cells and tumor immunity [J].
Chattopadhyay, S ;
Chakraborty, NG ;
Mukherji, B .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (12) :1153-1161
[6]   Cutting edge:: Decreased accumulation and regulatory function of CD4+CD25high T cells in human STAT 5b deficiency [J].
Cohen, Aileen C. ;
Nadeau, Kari C. ;
Tu, Wenwei ;
Hwa, Vivian ;
Dionis, Kira ;
Bezrodnik, Liliana ;
Teper, Alejandro ;
Gaillard, Maria ;
Heinrich, Juan ;
Krensky, Alan M. ;
Rosenfeld, Ron G. ;
Lewis, David B. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (05) :2770-2774
[7]   Differential regulation of T-cell growth by IL-2 and IL-15 [J].
Cornish, Georgina H. ;
Sinclair, Linda V. ;
Cantreli, Doreen A. .
BLOOD, 2006, 108 (02) :600-608
[8]   Future perspectives in the treatment of cutaneous T-cell lymphoma (CTCL) [J].
Dummer, R .
SEMINARS IN ONCOLOGY, 2006, 33 (01) :S33-S36
[9]  
Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103
[10]   FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with stage and survival [J].
Gjerdrum, L. M. ;
Woetmann, A. ;
Odum, N. ;
Burton, C. M. ;
Rossen, K. ;
Skovgaard, G. L. ;
Ryder, L. P. ;
Ralfkiaer, E. .
LEUKEMIA, 2007, 21 (12) :2512-2518